1 Table of Contents_x000D_
1.1 List of Tables_x000D_
1.2 List of Figures_x000D_
2 Introduction_x000D_
2.1 What Is This Report About?_x000D_
2.2 Diabetes Care Devices Market Segmentation_x000D_
2.3 Definitions of Markets Covered in the Report_x000D_
3 Diabetes Care Devices Market, Japan_x000D_
3.1 Diabetes Care Devices Market, Japan, Revenue ($m), 2018-2033_x000D_
3.2 Diabetes Care Devices Market, Japan, Revenue Mix ($m), 2023_x000D_
3.3 Diabetes Care Devices Market, Japan, Category Contribution by Revenue ($m), 2023_x000D_
3.4 Diabetes Care Devices Market, Japan, Revenue ($m), 2018-2033_x000D_
3.5 Diabetes Care Devices Market, Japan, Volume (Units), 2018-2033_x000D_
3.6 Diabetes Care Devices Market, Japan, Volume (Units), 2018-2033_x000D_
3.7 Diabetes Care Devices Market, Japan, Company Share by Revenue ($m), 2023_x000D_
4 Glucose Monitoring Market, Japan_x000D_
4.1 Glucose Monitoring Market, Japan, Revenue ($m), 2018-2033_x000D_
4.1.1 Blood Glucose Meters Market, Japan, Revenue ($m), by Segment, 2018-2033_x000D_
4.2 Glucose Monitoring Market, Japan, Volume (Units), 2018-2033_x000D_
4.2.1 Blood Glucose Meters Market, Japan, Volume (Units), by Segment, 2018-2033_x000D_
4.3 Glucose Monitoring Market, Japan, Average Price ($) , 2018-2033_x000D_
4.4 Glucose Monitoring Market, Japan, Distribution Share by Revenue ($m), 2023_x000D_
4.5 Glucose Monitoring Market, Japan, Company Share by Revenue ($m), 2023_x000D_
5 Insulin Delivery Market, Japan_x000D_
5.1 Insulin Delivery Market, Japan, Revenue Mix ($m), 2023_x000D_
5.2 Insulin Delivery Market, Japan, Segment Contribution (%), 2023_x000D_
5.3 Insulin Delivery Market, Japan, Revenue ($m), 2018-2033_x000D_
5.3.1 Insulin Pens Market, Japan, Revenue ($m), by Segment, 2018-2033_x000D_
5.3.2 Insulin Pumps Market, Japan, Revenue ($m), by Segment, 2018-2033_x000D_
5.4 Insulin Delivery Market, Japan, Volume (Units), 2018-2033_x000D_
5.4.1 Insulin Pens Market, Japan, Volume (Units), by Segment, 2018-2033_x000D_
5.4.2 Insulin Pumps Market, Japan, Volume (Units), by Segment, 2018-2033_x000D_
5.5 Insulin Delivery Market, Japan, Average Price ($) , 2018-2033_x000D_
5.6 Insulin Delivery Market, Japan, Distribution Share by Revenue ($m), 2023_x000D_
5.7 Insulin Delivery Market, Japan, Company Share by Revenue ($m), 2023_x000D_
6 Overview of Key Companies in Japan, Diabetes Care Devices Market_x000D_
6.1 Abbott Laboratories_x000D_
6.1.1 Company Overview_x000D_
6.2 Eli Lilly and Co_x000D_
6.2.1 Company Overview_x000D_
6.3 Sanofi_x000D_
6.3.1 Company Overview_x000D_
6.4 Medtronic Plc_x000D_
6.4.1 Company Overview_x000D_
6.5 Novo Nordisk AS_x000D_
6.5.1 Company Overview_x000D_
6.6 DexCom Inc_x000D_
6.6.1 Company Overview_x000D_
6.7 F. Hoffmann-La Roche Ltd_x000D_
6.7.1 Company Overview_x000D_
7 Diabetes Care Devices Market Pipeline Products_x000D_
8 Financial Deals Landscape_x000D_
8.1 Equity Offerings_x000D_
8.1.1 Terumo Raises USD1.26 Billion in Private Placement of Shares_x000D_
8.2 Private Equity_x000D_
8.2.1 Consortium of Investor Invest USD5.44 Million in Provigate_x000D_
9 Recent Developments_x000D_
9.1 Financial Announcements_x000D_
9.1.1 Aug 26, 2024: Senzime Releases Interim Report January – June 2024_x000D_
9.1.2 Apr 26, 2024: Nitto Denko Announces Consolidated Financial Statements for the Year Ended March 31, 2024_x000D_
9.2 Government and Public Interest_x000D_
9.2.1 Feb 14, 2024: GE HealthCare Management to Present at Upcoming Investor Conferences_x000D_
9.3 Other Significant Developments_x000D_
9.3.1 Oct 23, 2024: F. Hoffmann-La Roche Announces Third Quarter Sales 2024_x000D_
9.3.2 Mar 12, 2024: TOHO Group Will Participate in “ReMed New Life for Used Medical Device.”, a Recycling Project for Used Pre-filled Injection Pens, for the First Time in Japan_x000D_
9.4 Product News_x000D_
9.4.1 Sep 04, 2024: PHC Launches LiCellMo Live Cell Metabolic Analyzer for Real-Time Visualization of Cellular Metabolism in Cell and Gene Therapies_x000D_
9.4.2 Aug 30, 2024: PHC Unveils Prototype Of Licellgrow, New Cell Expansion System To Support Development Of Cell And Gene Therapy Products Manufacturing Process_x000D_
9.4.3 Aug 01, 2024: Development of a Method to Predict Onset of Non-Alcoholic Fatty Liver Disease —Contributing to Preventive Healthcare for Lifestyle Diseases_x000D_
9.4.4 Mar 12, 2024: TOHO Group Will Participate in “ReMed New Life for Used Medical Device.”, a Recycling Project for Used Pre-filled Injection Pens, for the First Time in Japan_x000D_
9.5 Strategy And Business Planning_x000D_
9.5.1 Feb 01, 2024: Strengthening the Direct Sales and Service System for Business Expansion in Italy_x000D_
9.5.2 Jan 16, 2024: Orbis International and Nidek Join Forces to Scale Up Artificial Intelligence Eye Screenings in Vietnam_x000D_
10 Appendix_x000D_
10.1 Research Methodology_x000D_
10.1.1 Coverage_x000D_
10.1.2 Secondary Research_x000D_
10.1.3 Primary Research_x000D_
10.1.4 Market Modeling and Forecasting_x000D_
10.1.5 Company Share Analysis_x000D_
10.1.6 Distribution Share Analysis_x000D_
10.1.7 Benchmarking_x000D_
10.2 GlobalData Consulting_x000D_
10.3 Contact Us_x000D_
10.4 Disclaimer